US Stock MarketDetailed Quotes

ANIX Anixa Biosciences

Watchlist
  • 2.990
  • -0.070-2.29%
Close Oct 17 16:00 ET
  • 2.970
  • -0.020-0.67%
Pre 08:17 ET
96.22MMarket Cap-7666P/E (TTM)

Anixa Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jul 31, 2024
(Q2)Apr 30, 2024
(Q1)Jan 31, 2024
(FY)Oct 31, 2023
(Q4)Oct 31, 2023
(Q3)Jul 31, 2023
(Q2)Apr 30, 2023
(Q1)Jan 31, 2023
(FY)Oct 31, 2022
(Q4)Oct 31, 2022
Total revenue
0
0
0
210K
0
0
210K
0
0
0
Operating revenue
--0
--0
--0
--210K
--0
--0
--210K
--0
--0
--0
Cost of revenue
0
0
161K
0
0
161K
0
0
Gross profit
0
0
49K
0
0
49K
0
0
Operating expense
26.30%3.59M
32.89%3.47M
41.20%3.61M
-20.29%11.06M
-15.46%3.05M
1.68%2.84M
-27.31%2.61M
-34.12%2.56M
4.61%13.88M
-11.46%3.61M
Selling and administrative expenses
-5.07%1.67M
13.04%1.82M
51.88%2.26M
-12.28%6.29M
-25.36%1.44M
29.88%1.76M
-13.11%1.61M
-27.13%1.49M
1.40%7.17M
1.10%1.92M
-General and administrative expense
-5.07%1.67M
13.04%1.82M
51.88%2.26M
-12.28%6.29M
-25.36%1.44M
29.88%1.76M
-13.11%1.61M
-27.13%1.49M
1.40%7.17M
1.10%1.92M
Research and development costs
76.93%1.93M
64.93%1.65M
26.31%1.35M
-28.85%4.77M
-4.15%1.62M
-24.71%1.09M
-42.48%998K
-41.89%1.07M
8.29%6.7M
-22.46%1.69M
Operating profit
-26.30%-3.59M
-35.43%-3.47M
-41.20%-3.61M
20.64%-11.01M
15.46%-3.05M
-1.68%-2.84M
28.67%-2.56M
34.12%-2.56M
-5.63%-13.88M
11.48%-3.61M
Net non-operating interest income expense
-6.42%277K
13.44%287K
57.92%319K
939.42%1.08M
312.50%330K
1,245.45%296K
25,200.00%253K
20,100.00%202K
5,100.00%104K
80K
Non-operating interest income
-6.42%277K
13.44%287K
57.92%319K
939.42%1.08M
312.50%330K
1,245.45%296K
25,200.00%253K
20,100.00%202K
5,100.00%104K
--80K
Other net income (expense)
Income before tax
-30.10%-3.32M
-37.84%-3.18M
-39.76%-3.29M
27.89%-9.93M
22.90%-2.72M
8.18%-2.55M
35.70%-2.31M
39.31%-2.35M
-4.90%-13.77M
13.31%-3.53M
Income tax
Net income
-30.10%-3.32M
-37.84%-3.18M
-39.76%-3.29M
27.89%-9.93M
22.90%-2.72M
8.18%-2.55M
35.70%-2.31M
39.31%-2.35M
-4.90%-13.77M
13.31%-3.53M
Net income continuous Operations
-30.10%-3.32M
-37.84%-3.18M
-39.76%-3.29M
27.89%-9.93M
22.90%-2.72M
8.18%-2.55M
35.70%-2.31M
39.31%-2.35M
-4.90%-13.77M
13.31%-3.53M
Minority interest income
-2.70%-38K
-115.79%-41K
-9.38%-35K
32.39%-119K
41.51%-31K
-27.59%-37K
56.82%-19K
36.00%-32K
-1.15%-176K
8.62%-53K
Net income attributable to the parent company
-30.51%-3.28M
-37.19%-3.14M
-40.18%-3.26M
27.83%-9.81M
22.61%-2.69M
8.56%-2.51M
35.44%-2.29M
39.36%-2.32M
-4.95%-13.6M
13.38%-3.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-30.51%-3.28M
-37.19%-3.14M
-40.18%-3.26M
27.83%-9.81M
22.61%-2.69M
8.56%-2.51M
35.44%-2.29M
39.36%-2.32M
-4.95%-13.6M
13.38%-3.48M
Basic earnings per share
-25.00%-0.1
-42.86%-0.1
-25.00%-0.1
28.89%-0.32
25.00%-0.09
11.11%-0.08
41.67%-0.07
38.46%-0.08
0.00%-0.45
7.69%-0.12
Diluted earnings per share
-25.00%-0.1
-42.86%-0.1
-25.00%-0.1
28.89%-0.32
25.00%-0.09
11.11%-0.08
41.67%-0.07
38.46%-0.08
0.00%-0.45
7.69%-0.12
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Jul 31, 2024(Q2)Apr 30, 2024(Q1)Jan 31, 2024(FY)Oct 31, 2023(Q4)Oct 31, 2023(Q3)Jul 31, 2023(Q2)Apr 30, 2023(Q1)Jan 31, 2023(FY)Oct 31, 2022(Q4)Oct 31, 2022
Total revenue 000210K00210K000
Operating revenue --0--0--0--210K--0--0--210K--0--0--0
Cost of revenue 00161K00161K00
Gross profit 0049K0049K00
Operating expense 26.30%3.59M32.89%3.47M41.20%3.61M-20.29%11.06M-15.46%3.05M1.68%2.84M-27.31%2.61M-34.12%2.56M4.61%13.88M-11.46%3.61M
Selling and administrative expenses -5.07%1.67M13.04%1.82M51.88%2.26M-12.28%6.29M-25.36%1.44M29.88%1.76M-13.11%1.61M-27.13%1.49M1.40%7.17M1.10%1.92M
-General and administrative expense -5.07%1.67M13.04%1.82M51.88%2.26M-12.28%6.29M-25.36%1.44M29.88%1.76M-13.11%1.61M-27.13%1.49M1.40%7.17M1.10%1.92M
Research and development costs 76.93%1.93M64.93%1.65M26.31%1.35M-28.85%4.77M-4.15%1.62M-24.71%1.09M-42.48%998K-41.89%1.07M8.29%6.7M-22.46%1.69M
Operating profit -26.30%-3.59M-35.43%-3.47M-41.20%-3.61M20.64%-11.01M15.46%-3.05M-1.68%-2.84M28.67%-2.56M34.12%-2.56M-5.63%-13.88M11.48%-3.61M
Net non-operating interest income expense -6.42%277K13.44%287K57.92%319K939.42%1.08M312.50%330K1,245.45%296K25,200.00%253K20,100.00%202K5,100.00%104K80K
Non-operating interest income -6.42%277K13.44%287K57.92%319K939.42%1.08M312.50%330K1,245.45%296K25,200.00%253K20,100.00%202K5,100.00%104K--80K
Other net income (expense)
Income before tax -30.10%-3.32M-37.84%-3.18M-39.76%-3.29M27.89%-9.93M22.90%-2.72M8.18%-2.55M35.70%-2.31M39.31%-2.35M-4.90%-13.77M13.31%-3.53M
Income tax
Net income -30.10%-3.32M-37.84%-3.18M-39.76%-3.29M27.89%-9.93M22.90%-2.72M8.18%-2.55M35.70%-2.31M39.31%-2.35M-4.90%-13.77M13.31%-3.53M
Net income continuous Operations -30.10%-3.32M-37.84%-3.18M-39.76%-3.29M27.89%-9.93M22.90%-2.72M8.18%-2.55M35.70%-2.31M39.31%-2.35M-4.90%-13.77M13.31%-3.53M
Minority interest income -2.70%-38K-115.79%-41K-9.38%-35K32.39%-119K41.51%-31K-27.59%-37K56.82%-19K36.00%-32K-1.15%-176K8.62%-53K
Net income attributable to the parent company -30.51%-3.28M-37.19%-3.14M-40.18%-3.26M27.83%-9.81M22.61%-2.69M8.56%-2.51M35.44%-2.29M39.36%-2.32M-4.95%-13.6M13.38%-3.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -30.51%-3.28M-37.19%-3.14M-40.18%-3.26M27.83%-9.81M22.61%-2.69M8.56%-2.51M35.44%-2.29M39.36%-2.32M-4.95%-13.6M13.38%-3.48M
Basic earnings per share -25.00%-0.1-42.86%-0.1-25.00%-0.128.89%-0.3225.00%-0.0911.11%-0.0841.67%-0.0738.46%-0.080.00%-0.457.69%-0.12
Diluted earnings per share -25.00%-0.1-42.86%-0.1-25.00%-0.128.89%-0.3225.00%-0.0911.11%-0.0841.67%-0.0738.46%-0.080.00%-0.457.69%-0.12
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data